Skip to content
  • CONTACT US
  • CAREERS
  • Share
Allogene Logo
  • PIPELINE
    • AlloCAR T™ PRODUCT PIPELINE
    • THE ALPHA3 TRIAL
    • DATABRIEF
    • EXPANDED ACCESS
  • SCIENCE
    • NEXT REVOLUTION IN CELL THERAPY
    • PLATFORM FOR TOMORROW
    • ON-DEMAND AVAILABILITY
    • SCIENTIFIC PUBLICATIONS
  • ABOUT US
    • AT A GLANCE
    • MANAGEMENT TEAM
    • BOARD OF DIRECTORS
    • SCIENTIFIC ADVISORS
    • PARTNERS
    • CORPORATE RESPONSIBILITY
  • NEWS CENTER
    • PRESS RELEASES
    • EVENTS
    • PERSPECTIVES
    • SOCIAL MEDIA
    • COMMUNITY GUIDELINES
  • INVESTORS
    • IR OVERVIEW
    • NEWS & EVENTS
      • PRESS RELEASES
      • EVENTS
      • PRESENTATIONS
    • STOCK INFORMATION
      • STOCK QUOTE & CHART
      • HISTORIC PRICE LOOKUP
      • INVESTMENT CALCULATOR
    • CORPORATE GOVERNANCE
      • DOCUMENTS & CHARTERS
      • BOARD OF DIRECTORS
      • MANAGEMENT
      • COMMITTEE COMPOSITION
    • FINANCIALS & FILINGS
      • SEC FILINGS
    • RESOURCES
      • INVESTOR FAQs
      • EMAIL ALERTS
      • IR INQUIRY
  • PIPELINE
    • AlloCAR T™ PRODUCT PIPELINE
    • THE ALPHA3 TRIAL
    • DATABRIEF
    • EXPANDED ACCESS
  • SCIENCE
    • NEXT REVOLUTION IN CELL THERAPY
    • PLATFORM FOR TOMORROW
    • ON-DEMAND AVAILABILITY
    • SCIENTIFIC PUBLICATIONS
  • ABOUT US
    • AT A GLANCE
    • MANAGEMENT TEAM
    • BOARD OF DIRECTORS
    • SCIENTIFIC ADVISORS
    • PARTNERS
    • CORPORATE RESPONSIBILITY
  • NEWS CENTER
    • PRESS RELEASES
    • EVENTS
    • PERSPECTIVES
    • SOCIAL MEDIA
    • COMMUNITY GUIDELINES
  • INVESTORS
    • IR OVERVIEW
    • NEWS & EVENTS
      • PRESS RELEASES
      • EVENTS
      • PRESENTATIONS
    • STOCK INFORMATION
      • STOCK QUOTE & CHART
      • HISTORIC PRICE LOOKUP
      • INVESTMENT CALCULATOR
    • CORPORATE GOVERNANCE
      • DOCUMENTS & CHARTERS
      • BOARD OF DIRECTORS
      • MANAGEMENT
      • COMMITTEE COMPOSITION
    • FINANCIALS & FILINGS
      • SEC FILINGS
    • RESOURCES
      • INVESTOR FAQs
      • EMAIL ALERTS
      • IR INQUIRY
Read more about the article “Off-the-shelf” CAR T – New frontiers in autoimmune disease

“Off-the-shelf” CAR T – New frontiers in autoimmune disease

  • Post author:andrewkaretas
  • Post published:May 7, 2025
  • Post category:Perspectives

Continue Reading“Off-the-shelf” CAR T – New frontiers in autoimmune disease
Read more about the article New Frontiers for CAR-T

New Frontiers for CAR-T

  • Post author:andrewkaretas
  • Post published:November 1, 2024
  • Post category:Perspectives

Continue ReadingNew Frontiers for CAR-T
Read more about the article FT US Pharma and Biotech Summit

FT US Pharma and Biotech Summit

  • Post author:andrewkaretas
  • Post published:June 12, 2024
  • Post category:Perspectives/Uncategorized

Continue ReadingFT US Pharma and Biotech Summit
Read more about the article Unlocking the Fourth Great Wave in Cancer Treatment

Unlocking the Fourth Great Wave in Cancer Treatment

  • Post author:andrewkaretas
  • Post published:November 8, 2023
  • Post category:Perspectives

Continue ReadingUnlocking the Fourth Great Wave in Cancer Treatment
Read more about the article The CAR T Revolution Continues: Progress Against Solid Tumors

The CAR T Revolution Continues: Progress Against Solid Tumors

  • Post author:andrewkaretas
  • Post published:May 2, 2023
  • Post category:Perspectives

Continue ReadingThe CAR T Revolution Continues: Progress Against Solid Tumors
Read more about the article Reuniting for the Next Revolution of CAR T

Reuniting for the Next Revolution of CAR T

  • Post author:andrewkaretas
  • Post published:January 6, 2023
  • Post category:Perspectives

Continue ReadingReuniting for the Next Revolution of CAR T
Read more about the article A First-of-its-Kind Initiative with Leading Oncologists Hopes to Usher in the Allogeneic Cell Therapy Revolution…

A First-of-its-Kind Initiative with Leading Oncologists Hopes to Usher in the Allogeneic Cell Therapy Revolution…

  • Post author:andrewkaretas
  • Post published:October 11, 2022
  • Post category:Perspectives

Continue ReadingA First-of-its-Kind Initiative with Leading Oncologists Hopes to Usher in the Allogeneic Cell Therapy Revolution…
Read more about the article Initiating the First Allogeneic CAR T Phase 2 Trial

Initiating the First Allogeneic CAR T Phase 2 Trial

  • Post author:andrewkaretas
  • Post published:October 6, 2022
  • Post category:Perspectives

Continue ReadingInitiating the First Allogeneic CAR T Phase 2 Trial
Read more about the article Welcome Cell Forge 1: The Future of Cancer Therapy Manufacturing

Welcome Cell Forge 1: The Future of Cancer Therapy Manufacturing

  • Post author:Allogene Admin
  • Post published:May 25, 2022
  • Post category:Perspectives

Continue ReadingWelcome Cell Forge 1: The Future of Cancer Therapy Manufacturing
Read more about the article Developing Life-Changing Treatments for Blood Cancer

Developing Life-Changing Treatments for Blood Cancer

  • Post author:andrewkaretas
  • Post published:September 8, 2021
  • Post category:Perspectives

Continue ReadingDeveloping Life-Changing Treatments for Blood Cancer
  • 1
  • 2
  • Go to the next page
Allogene

CONNECT

210 E. Grand Avenue
South San Francisco, CA 94080

View Map / Contact Us

LinkedIn
X (Twitter)
  • PIPELINE
    • AlloCAR T™ Product Pipeline
    • THE ALPHA3 TRIAL
    • DATABRIEF
    • Expanded Access
  • SCIENCE
    • Next Revolution in Cell Therapy
    • Platform for Tomorrow
    • On-Demand Availability
    • Scientific Publications
  • ABOUT US
    • At a Glance
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Partners
    • Corporate Responsibility
  • NEWS CENTER
    • Press Releases
    • Events
    • Perspectives
    • Social Media
    • Community Guidelines
  • INVESTORS
    • Press Releases
    • Events
    • Presentations
    • Stock Information
    • Stock Quote & Chart
    • Historical Price Look Up
    • Investment Calculator
    • Corporate Governance
    • Documents & Charters
  • INVESTORS
    • Board of Directors
    • Management
    • Committee Composition
    • SEC Filings
    • Resources
    • Investor FAQs
    • Email Alerts
    • IR Inquiry
Facebook
X (Twitter)
LinkedIn
E-Mail
Tumblr
Reddit
WhatsApp
Telegram
Allogene

CONNECT

210 E. Grand Avenue
South San Francisco, CA 94080

View Map / Contact Us

LinkedIn
X (Twitter)
  • PIPELINE
    • AlloCAR T™ Product Pipeline
    • THE ALPHA3 TRIAL
    • DATABRIEF
    • Expanded Access
  • SCIENCE
    • Next Revolution in Cell Therapy
    • Platform for Tomorrow
    • On-Demand Availability
    • Scientific Publications
  • ABOUT US
    • At a Glance
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Partners
    • Corporate Responsibility
  • NEWS CENTER
    • Press Releases
    • Events
    • Perspectives
    • Social Media
    • Community Guidelines
  • INVESTORS
    • Press Releases
    • Events
    • Presentations
    • Stock Information
    • Stock Quote & Chart
    • Historical Price Look Up
    • Investment Calculator
    • Corporate Governance
    • Documents & Charters
  • INVESTORS
    • Board of Directors
    • Management
    • Committee Composition
    • SEC Filings
    • Resources
    • Investor FAQs
    • Email Alerts
    • IR Inquiry

©2024 ALLOGENE THERAPEUTICS

TERMS OF USE

COOKIE SETTINGS

PRIVACY NOTICE

©2024 ALLOGENE THERAPEUTICS

TERMS OF USE

COOKIE SETTINGS

PRIVACY NOTICE